Literature DB >> 25085705

Comparison of metabolic profile and abdominal fat distribution between karyotypically normal women with premature ovarian insufficiency and age matched controls.

Seda Ates1, Gozde Yesil2, Osman Sevket3, Taner Molla3, Seyma Yildiz4.   

Abstract

OBJECTIVE: We designed a prospective case-control study in order to investigate the lipid profiles, insulin sensitivity, presence of metabolic syndrome (MetS) and the abdominal fat distribution in karyotypically normal women with premature ovarian insufficiency (POI).
METHODS: Anthropometric measurements, FSH, estradiol, total testosterone (T), sex hormone binding globulin (SHBG), free androgen index (FAI), fasting glucose and insulin, homeostatic model for insulin resistance (HOMA-IR), lipid profile, the prevalence of MetS and ultrasonographic abdominal fat measurements were assessed in 56 women with POI and 59 healthy controls at the same age range.
RESULTS: Serum levels of T, SHBG and FAI were not significantly different between both groups. Total cholesterol (TC) and high-density lipoprotein cholesterol (HDL-C) were higher in women with POI. There were no differences in glucose, insulin, HOMA-IR, low-density lipoprotein cholesterol (LDL-C), triglyceride levels between the two groups. A significant positive correlation was identified between T and TG and also between FAI and LDL-C; SHBG levels were correlated inversely with FSH, and positively with HDL-C in women with POI. The presence of MetS was significantly higher in women with POI. The subcutaneous, preperitoneal and visceral fat thicknesses were not significantly different between the groups.
CONCLUSIONS: Early cessation of ovulatory function may associated with higher levels of serum TC and HDL-C, but does not seem to cause differences in abdominal fat distribution in women with POI. POI is associated with higher risk of MetS.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Body fat; Hypertension; Insulin resistance; Lipid profile; Metabolic syndrome; Premature ovarian failure

Mesh:

Substances:

Year:  2014        PMID: 25085705     DOI: 10.1016/j.maturitas.2014.07.008

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  11 in total

1.  Lipid Profile in Patients With Primary Ovarian Insufficiency: A Systematic Review and Meta-Analysis.

Authors:  Ling Huang; Hanfeng Wang; Minglu Shi; Weizheng Kong; Mei Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-10       Impact factor: 6.055

2.  The role of ADAMTS4 and ADAMTS9 in cardiovascular disease in premature ovarian insufficiency and idiopathic hypogonadotropic hypogonadism.

Authors:  S Ozler; E Isci Bostanci; E Oztas; M Kuru Pekcan; B Gumus Guler; N Yilmaz
Journal:  J Endocrinol Invest       Date:  2018-09-05       Impact factor: 4.256

Review 3.  Current Understanding of the Etiology, Symptomatology, and Treatment Options in Premature Ovarian Insufficiency (POI).

Authors:  Bunpei Ishizuka
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

4.  There is No Association between Premature Ovarian Insufficiency and Levels of Fetuin-A/α2-Heremans-Schmid Glycoprotein.

Authors:  A Seval Ozgu-Erdinc; Zeynep Asli Oskovi Kaplan; Yaprak Engin-Ustun; Nafiye Yilmaz; Gulcin Yildirim; Aytekin Tokmak; Kudret Erkenekli; Salim Erkaya; Dilek Uygur
Journal:  J Hum Reprod Sci       Date:  2019-12-17

5.  Hormone Replacement Therapy Reverses Gut Microbiome and Serum Metabolome Alterations in Premature Ovarian Insufficiency.

Authors:  Lingling Jiang; Haiyi Fei; Jinfei Tong; Jiena Zhou; Jiajuan Zhu; Xiaoying Jin; Zhan Shi; Yan Zhou; Xudong Ma; Hailan Yu; Jianhua Yang; Songying Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-23       Impact factor: 5.555

6.  Does the Value of FSH Predict Severity of Metabolic Complications in Females with POI?

Authors:  Michał Kunicki; Jagoda Kruszewska; Jolanta Skórska; Hanna Laudy-Wiaderny; Marcin Wrona; Roman Smolarczyk
Journal:  J Clin Med       Date:  2022-04-05       Impact factor: 4.241

7.  BNC1 deficiency-triggered ferroptosis through the NF2-YAP pathway induces primary ovarian insufficiency.

Authors:  Feixia Wang; Yifeng Liu; Feida Ni; Jiani Jin; Yiqing Wu; Yun Huang; Xiaohang Ye; Xilin Shen; Yue Ying; Jianhua Chen; Ruixue Chen; Yanye Zhang; Xiao Sun; Siwen Wang; Xiao Xu; Chuan Chen; Jiansheng Guo; Dan Zhang
Journal:  Nat Commun       Date:  2022-10-05       Impact factor: 17.694

Review 8.  Premature ovarian insufficiency: the context of long-term effects.

Authors:  A Podfigurna-Stopa; A Czyzyk; M Grymowicz; R Smolarczyk; K Katulski; K Czajkowski; B Meczekalski
Journal:  J Endocrinol Invest       Date:  2016-04-18       Impact factor: 4.256

9.  Metabolic Profile of Patients with Premature Ovarian Insufficiency.

Authors:  Agnieszka Podfigurna; Angelika Stellmach; Anna Szeliga; Adam Czyzyk; Blazej Meczekalski
Journal:  J Clin Med       Date:  2018-10-21       Impact factor: 4.241

10.  Serum androgen profiles in women with premature ovarian insufficiency: a systematic review and meta-analysis.

Authors:  Midhun Soman; Li-Cong Huang; Wen-Hui Cai; Jun-Bi Xu; Jun-Yao Chen; Ren-Ke He; Heng-Chao Ruan; Xiang-Rong Xu; Zhi-Da Qian; Xiao-Ming Zhu
Journal:  Menopause       Date:  2019-01       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.